{ "schema_version": "0.1.0", "id": "fda-drug-shortage:amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-saccharate-dextroamphetamine-sulfate-tablet", "slug": "amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-saccharate-dextroamphetamine-sulfate-tablet", "title": "FDA shortage status: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "ingredient": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "status": "current", "source_statuses": [ "Current" ], "brand_names": [ "ADDERALL", "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "therapeutic_categories": [ "Psychiatry" ], "dosage_forms": [ "Tablet" ], "routes": [ "ORAL" ], "package_count": 73, "packages": [ { "package_ndc": "47781-176-01", "product_ndc": "47781-174", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-178-01", "product_ndc": "47781-174", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-179-01", "product_ndc": "47781-174", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-180-01", "product_ndc": "47781-174", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-174-01", "product_ndc": "47781-174", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-068-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-069-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-070-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-072-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-073-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "13107-074-01", "product_ndc": "13107-068", "company_name": "Aurobindo Pharma USA", "manufacturer_name": "Aurolife Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "07/21/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-500-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-501-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-502-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-503-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-504-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-505-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-506-01", "product_ndc": "64850-500", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "08/15/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42806-339-01", "product_ndc": "42806-339", "company_name": "Epic Pharma, LLC", "manufacturer_name": "Epic Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)", "availability": "Limited Availability", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42806-341-01", "product_ndc": "42806-339", "company_name": "Epic Pharma, LLC", "manufacturer_name": "Epic Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42806-343-01", "product_ndc": "42806-339", "company_name": "Epic Pharma, LLC", "manufacturer_name": "Epic Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42806-344-01", "product_ndc": "42806-339", "company_name": "Epic Pharma, LLC", "manufacturer_name": "Epic Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)", "availability": "Limited Availability", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42806-345-01", "product_ndc": "42806-339", "company_name": "Epic Pharma, LLC", "manufacturer_name": "Epic Pharma, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-111-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-112-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-113-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-114-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-115-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-116-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "70010-117-01", "product_ndc": "70010-111", "company_name": "Granules Pharmaceuticals Inc.", "manufacturer_name": "Granules Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-0760-37", "product_ndc": "0527-0760", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-0761-37", "product_ndc": "0527-0760", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-1502-37", "product_ndc": null, "company_name": "Lannett Company, Inc.", "manufacturer_name": null, "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-0763-37", "product_ndc": "0527-0760", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-0764-37", "product_ndc": "0527-0760", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-1505-37", "product_ndc": null, "company_name": "Lannett Company, Inc.", "manufacturer_name": null, "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-0766-37", "product_ndc": "0527-0760", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "72516-016-01", "product_ndc": "72516-011", "company_name": "Oryza Pharmaceuticals Inc.", "manufacturer_name": "Oryza Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "72516-014-01", "product_ndc": "72516-011", "company_name": "Oryza Pharmaceuticals Inc.", "manufacturer_name": "Oryza Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "72516-013-01", "product_ndc": "72516-011", "company_name": "Oryza Pharmaceuticals Inc.", "manufacturer_name": "Oryza Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "72516-012-01", "product_ndc": "72516-011", "company_name": "Oryza Pharmaceuticals Inc.", "manufacturer_name": "Oryza Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "72516-011-01", "product_ndc": "72516-011", "company_name": "Oryza Pharmaceuticals Inc.", "manufacturer_name": "Oryza Pharmaceuticals Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0185-2098-01", "product_ndc": "0185-0831", "company_name": "Sandoz Inc.", "manufacturer_name": "Sandoz Inc", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0185-0842-01", "product_ndc": "0185-0831", "company_name": "Sandoz Inc.", "manufacturer_name": "Sandoz Inc", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0185-0853-01", "product_ndc": "0185-0831", "company_name": "Sandoz Inc.", "manufacturer_name": "Sandoz Inc", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0185-2099-01", "product_ndc": "0185-0831", "company_name": "Sandoz Inc.", "manufacturer_name": "Sandoz Inc", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8891-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)", "availability": "Limited Availability", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8884-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8892-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)", "availability": "Limited Availability", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8885-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8893-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-8894-01", "product_ndc": "0406-8884", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)", "availability": "Limited Availability", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-190-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-191-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-192-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-193-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-194-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-195-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "11534-196-01", "product_ndc": "11534-190", "company_name": "Sunrise Pharmaceutical, Inc.", "manufacturer_name": "SUNRISE PHARMACEUTICAL, INC.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/16/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-105-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-117-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-110-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-112-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)", "availability": "Unavailable", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-115-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-120-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57844-130-01", "product_ndc": "57844-105", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0971-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0775-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0972-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0776-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0777-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0973-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0555-0974-02", "product_ndc": "0555-0775", "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": "Teva Pharmaceuticals USA, Inc.", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)", "availability": "Available", "dosage_form": "Tablet", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "10/12/2022", "source_url": "https://api.fda.gov/drug/shortages.json" } ], "availability_counts": { "Available": 49, "Limited Availability": 5, "Unavailable": 19 }, "initial_posting_date": "08/15/2023", "latest_source_update": "08/20/2026", "source_updated_at": "2026-08-22", "official_url": "https://api.fda.gov/drug/shortages.json", "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages", "source_license_url": "https://open.fda.gov/license/", "retrieved_at": "2026-08-22T15:54:11+00:00", "unknowns": { "local_availability": "Unknown. FDA status is nationwide and is not local inventory.", "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.", "resolution_date": "Unknown unless an FDA source row provides an update date." }, "derivations": { "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.", "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.", "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply." } }